LOTUSEYE112.50

Lotus Eye Hospital and Institute Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹234 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation3.73.03.7
+ Finance Costs0.10.40.9
+ Interest Income-0.5-0.4-0.2
+ Other — Cash Effects are Investing / Financing-0.4-0.4-0.5
+ Other Reconciling Items-0.0-0.00.0
Changes in Working Capital
+ Inventories-0.4-0.6-0.0
+ Trade Receivables — Current-0.1-0.10.1
+ Other Financial Assets — Non-current0.0-0.0-0.2
+ Other Current Assets-0.20.2-0.2
+ Other Non-current Assets-0.60.0-0.8
+ Other Bank Balances0.02.20.1
+ Trade Payables — Current0.3-0.1-0.1
+ Trade Payables — Non-current0.1-0.10.0
+ Other Financial Liabilities — Current0.00.20.7
+ Other Financial Liabilities — Non-current0.00.0-0.0
+ Other Current Liabilities0.8-0.1-0.0
+ Other Non-current Liabilities-0.00.00.0
+ Provisions — Current0.0-0.1-0.0
+ Provisions — Non-current-0.10.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)4.01.4-0.1
+ Total Adjustments (incl. Working Capital)2.74.23.5
Cash from Operations (pre-tax)6.75.63.4
+ Income Taxes Paid1.00.60.3
Cash from Operating Activities5.74.93.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)5.64.813.0
+ Disp of Fixed Assets0.10.00.0
+ Interest Received — Investing0.50.40.2
+ Other Inflows / (Outflows) — Investing0.40.40.5
Cash from Investing Activities-4.6-4.0-12.4
Cash from Financing Activities
+ Proceeds from Borrowings0.00.015.0
+ Repayment of Borrowings0.00.03.6
+ Payment of Lease Liabilities2.31.21.6
+ Interest Paid0.10.40.8
+ Dividends Paid1.00.00.0
Cash from Financing Activities-3.4-1.69.0
Net Changes in Cash (pre-FX)-2.4-0.6-0.2
Net Changes in Cash-2.4-0.6-0.2
Closing Cash6.9
Reference Items
EBITDA6.53.43.4
EBITDA Margin %13.556.936.30
Free Cash Flow (CFO − Capex)0.00.1-9.9
Free Cash Flow to Equity-0.20.7
Free Cash Flow per Basic Share0.020.06-4.76
Cash Flow to Net Income1.956.6939.03
Cash Paid for Taxes1.00.60.3
Cash Paid for Interest0.10.40.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.